The role of the matrix metalloproteinases in human endometrial and ovarian cycles

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 111, Issue 2, 2003, Pages 109-121

  Goldman, Shlomit ^a   Shalev, Eliezer ^a,b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Endometrium; Matrix metalloproteinases; Ovary; TIMP

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 20; MATRIX METALLOPROTEINASE 23; MATRIX METALLOPROTEINASE 24; MATRIX METALLOPROTEINASE 25; MATRIX METALLOPROTEINASE 26; MATRIX METALLOPROTEINASE 27; MATRIX METALLOPROTEINASE 28; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

ANGIOGENESIS; AUTOCRINE EFFECT; CELL INVASION; CORPUS LUTEUM FUNCTION; ENDOCRINE FUNCTION; ENDOMETRIUM; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STRUCTURE; FEMALE GENITAL SYSTEM FUNCTION; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; MENSTRUATION; OVARY; OVARY CYCLE; OVARY FOLLICLE DEVELOPMENT; OVULATION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

EID: 0242365363     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00341-5     Document Type: Review

References (101)

1. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:2001;463-516.
2. Thiennu H.Vu., Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Gene Dev. 14:2000;2123-2133.
3. Pepper M.S. Role of the matrix metalloproteinases and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb. Vasc. Biol. 21:2001;1104-1117.
4. Bode W., Fernandez-Catalan C., Tschesche H., Grams F., Nagase H., Maskos K. Structural properties of matrix metalloproteinases. Cell Mol. Life Sci. 55:1999;639-652.
5. Velasco G., Pendas A.M., Fueyo A., Knauper V., Murphy G., Lopez-Otin C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domain in other family members. J. Biol. Chem. 274:1999;4570-4576.
6. Okumura Y., Sato H., Seiki M., Kido H. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator. FEBS Lett. 402:1997;181-184.
7. Brew K., Dinakarpandian D., Nagase H. Tissue inhibitors of metalloproteinases: evolution. Biochim. Biophys. Acta. 1477:2000;267-283.
8. Goldberg G.I., Marmer B.L., Grant G.A., Eisen A.Z., Wilhelm S., He C.S. Human 72 kDa type IV collagenases forma a complex with tissue inhibitor of metalloproteinases designated TIMP-2. Proc. Natl. Acad. Sci. U.S.A. 86:1989;8207-8211.
9. Murphy G., Knauper V. Relating matrix metalloproteinases structure to function: why the 'hemopexin' domain? Matrix Biol. 15:1997;511-518.
10. Curry T.E. Jr., Osteen K.G. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol. Reprod. 64:2001;1285-1296.
11. Hulboy D.L., Rudolph L.A., Matrisian L.M. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod. 3:1997;27-45.
12. Speroff L, Glass RH, Kase NG, editors. Clinical gynecologic endocrinology and infertility. Baltimore: Lippincott Williams & Wilkins; 1999. p. 127-30.
13. Rodgers W.H., Matrisian L.M., Giudice L., Dsupin B., Cannon P., Svitek C.et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J. Clin. Invest. 94:1994;946-953.
14. Brenner R.M., Rudolph L.A., Matrisian L.M., Slayden O.D. Nonhuman primate models: artificial menstrual cycles, endometrial matrix metalloproteinases and subcutaneous endometrial grafts. Hum. Reprod. 11(Suppl. 2):1996;150-164.
15. Hampton A.L., Butt A.R., Riley S.C., Salamonsen L.A. Tissue inhibitors of metalloproteinases in endometrium of ovariectomized steroid treated ewes and during the estrous cycle of early pregnancy. Biol. Reprod. 53:1995;302-311.
16. Irwin J.C., Kirk D., Gwatkin R.B., Navre M., Cannon P., Giudice L.C. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J. Clin. Invest. 97:1996;438-447.
17. Jeziorska M., Nagase H., Salamonsen L.A., Woolley D.E. Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. J. Reprod. Fertil. 107:1996;43-51.
18. Skinner J.L., Riley S.C., Gebbie A.E., Glasier A.F., Critchley H.O. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum. Reprod. 14:1999;793-799.
19. Rigot V., Marbaix E., Lemoine P., Courtoy P.J., Eeckhout Y. In vivo perimenstrual activation of progelatinase B (proMMP-9) in the human endometrium and its dependence on stromelysin 1 (MMP-3) ex vivo. Biochem. J. 358:2001;275-280.
20. Zhang J., Salamonsen L.A. Tissue inhibitor of metalloproteinases (TIMP)-1, 2 and 3 in human endometrium during the menstrual cycle. Mol. Hum. Reprod. 3:1997;735-741.
21. Higuchi T., Kanzaki H., Nakayama H., Fujimoto M., Hatayama H., Kojima K.et al. Induction of tissue inhibitor of metalloproteinase 3 gene expression during in vitro decidualization of human endometrial stromal cells. Endocrinology. 136:1995;4973-4981.
22. Woessner JF. The matrix metalloproteinases family. In: Parks WC, Mecham RP, editors. Matrix metalloproteinases. San Diego: Academic Press; 1998. p. 1-14.
23. Aimes R.T., Quigley J.P. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J. Biol. Chem. 270:1995;5872-5876.
24. Murphy G., Crabbe T. Gelatinases A and B. Methods Enzymol. 248:1995;470-584.
25. Schnaper H.W., Grant D.S., Stetler-Stevenson W.G., Fridman R., D'Orazi G., Murphy A.N.et al. Type IV collagenases and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell Physiol. 156:1993;235-246.
26. Brooks P.C., Silletti S., von Schalscha T.L., Friedlander M., Cheresh D.A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell. 92:1998;391-400.
27. 3 . Cell. 85:1996;683-693.
28. Martin P. Wound healing-aiming for perfect skin regeneration. Science. 276:1997;75-81.
29. Creemers E., Cleutjens J., Smits J., Heymans S., Moons L., Collen D.et al. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am. J. Pathol. 156:2000;1865-1873.
30. Agren M.S., Mirastschijski U., Karlsmark T., Saarialho-Kere U.K. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp. Dermatol. 10:2001;337-348.
31. Lijnen H.R. Elements of the fibrinolytic system. Ann. N. Y. Acad. Sci. 936:2001;226-236.
32. Hickey M., Higham J., Sullivan M., Miles L., Fraser I.S. Endometrial bleeding in hormone replacement therapy users: preliminary findings regarding the role of matrix metalloproteinase 9 (MMP-9) and tissue inhibitors of MMPs. Fertil. Steril. 75:2001;288-296.
33. Roh C.R., Oh W.J., Yoon B.K., Lee J.H. Up-regulation of matrix metalloproteinase-9 in human myometrium during labour: a cytokine-mediated process in uterine smooth muscle cells. Mol. Hum. Reprod. 1:2000;96-102.
34. Potier M., Elliot S.J., Tack I., Lenz O., Striker G.E., Striker L.J.et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J. Am. Soc. Nephrol. 12:2001;241-251.
35. Zhao H., Xia Z., Cai G., Du J., Zhu T., Shen L. Expression of type I collagen and matrix metalloproteinase-9 mRNA in bone of castrated adult female rats: effects of estrogen. Chin. Med. J. (Engl.). 111:1998;551-555.
36. Selam B., Kayisli U.A., Mulayim N., Arici A. Regulation of Fas ligand expression by estradiol and progesterone in human endometrium. Biol. Reprod. 65:2001;979-985.
37. Frisch S.M., Morasaki J.H. Positive and negative transcriptional elements of the human type IV collagenase gene. Mol. Cell. Biol. 12:1990;6524-6532.
38. Templeton N.S., Stetler Stevenson W.G. Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. Cancer Res. 51:1991;6190-6193.
39. Lewalle J.M., Munaut C., Pichot B., Cataldo D., Baramova E., Foidart J.M. Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J. Cell Physiol. 165:1995;475-483.
40. Nguyen M., Arkell J., Jackson C.J. Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP. Int. J. Biochem. Cell Biol. 32:2000;621-631.
41. Nakano M., Hara T., Hayama T., Obara M., Yoshizato K., Ohama K. Membrane-type 1 matrix metalloproteinase is induced in decidual stroma without direct invasion by trophoblasts. Mol. Hum. Reprod. 7:2001;271-277.
42. Atkinson S.J., Patterson M.L., Butler M.J., Murphy G. Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type I collagen in a cell model. FEBS Lett. 491:2001;222-226.
43. Nguyen M., Arkell J., Jackson C.J. Activated protein C directly activates human endothelial gelatinase A. J. Biol. Chem. 275:2000;9095-9098.
44. Pekovich S.R., Bock P.E., Hoover R.L. Thrombin-thrombomodulin activation of protein C facilitates the activation of progelatinase A. FEBS Lett. 494:2001;129-132.
45. Wiener-Megnagi Z., Ben-Shlomo I., Goldberg Y., Shalev E. Resistance to activated protein C and the Leiden mutation: high prevalence in patients with placental abruption. Am. J. Obstet. Gynecol. 179:1998;1565-1567.
46. Marbaix E., Donnez J., Courtoy P.J., Eeckhout Y. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc. Natl. Acad. Sci. U.S.A. 89:1992;11789-11793.
47. Schatz F., Papp C., Toth-Pal E., Lockwood C.J. Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells. J. Clin. Endocrinol. Metabol. 78:1994;1467-1472.
48. Bruner K.L., Rodgers W.H., Gold L.I., Korc M., Hargrove J.T., Matrisian L.M.et al. Transforming growth factor α mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7362-7366.
49. Marbaix E., Kokorine I., Henriet P., Donnez J., Courtoy P.J., Eeckhout Y. The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem. J. 305:1995;1027-1030.
50. Osteen K.G., Sierra-Rivera E., Keller N.R. Interleukin-1 alpha opposes progesterone-mediated suppression of MMP-7. A possible role of this cytokine during human implantation. Ann. N. Y. Acad. Sci. 828:1997;137-145.
51. Singer C.F., Marbaix E., Kokorine I., Lemoine P., Donnez J., Eeckhout Y.et al. Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10341-10345.
52. Hampton A.L., Nie G., Salamonsen L.A. Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects. Mol. Hum. Reprod. 5:1999;365-371.
53. Murphy G., Stanton H., Cowell S., Butler G., Knauper V., Atkinson S.et al. Mechanisms for pro matrix metalloproteinase activation. APMIS. 107:1999;38-44.
54. Osteen K.G., Keller N.R., Feltus F.A., Melner M.H. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Gynecol. Obstet. Invest. 48(Suppl. 1):1999;2-13.
55. Salamonsen L.A., Woolley D.E. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J. Reprod. Immunol. 44:1999;1-27.
56. Salamonsen L.A., Butt A.R., Hammond F.R., Garcia S., Zhang J. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J. Clin. Endocrinol. Metabol. 82:1997;1409-1415.
57. Lockwood C.J., Krikun G., Hausknecht V.A., Papp C., Schatz F. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal. Endocrinology. 139:1998;4607-4613.
58. Keller N.R., Sierra-Rivera E., Eisenberg E., Osteen K.G. Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1alpha in human endometrial stromal cells. J. Clin. Endocrinol. Metab. 85:2000;1611-1619.
59. Marbaix E., Kokorine I., Moulin P., Donnez J., Eeckhout Y., Courtoy P.J. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9120-9125.
60. Tabibzadeh S., Satyaswaroop P.G., von Wolff M., Strowitzki T. Regulation of TNF-α mRNA expression in endometrial cells by TNF-α and by oestrogen withdrawal. Mol. Hum. Reprod. 5:1999;1141-1149.
61. Tabibzadeh S. Signal and molecular pathways involved in apoptosis with special emphasis on human endometrium. Hum. Mol. Reprod. Update. 1:1995;303-323.
62. Rawdanowicz T.J., Hampton A.L., Nagase H., Woolley D.E., Salamonsen L.A. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J. Clin. Endocrinol. Metabol. 79:1994;530-536.
63. Zhang J., Nie G., Jian W., Woolley D.E., Salamonsen L.A. Mast cell regulation of human endometrial matrix metalloproteinases: a mechanism underlying menstruation. Biol. Reprod. 59:1998;693-703.
64. Nguyen M., Arkell J., Jackson C.J. Active and tissue inhibitors of matrix metalloproteinases-free gelatinase B accumulates within human microvascular endothelial vesicle. J. Biol. Chem. 273:1998;5400-5404.
65. Olson M.W., Bernardo M.M., Pietila M., Gervasi D.C., Toth M., Kotra L.P.et al. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9: differential rates for activation by stromelysin. J. Biol. Chem. 275:2000;2661-2668.
66. Fridman R., Toth M., Pena D. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55:1995;2548-2555.
67. Sang Q.X., Birkedal-Hansen H., Van Wart H.E. Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim. Biophys. Acta. 125:1995;99-108.
68. Desrivieres S., Lu H., Peyri N., Soria C., Legrand Y., Menashi S. Activation of the 92. kDa type IV collagenase by tissue kallikrein J. Cell. Physiol. 157:1993;587-593.
69. Makowski G.S., Ramsby M.L. Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway. Inflammatory. 22:1998;287-305.
70. Vincent A.J., Salamonsen L.A. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum. Reprod. 15(Suppl. 3):2000;135-143.
71. Lathbury L.J., Salamonsen L.A. In vitro study of the potential role of neutrophils in the process of menstruation. Mol. Hum. Reprod. 6:2000;899-906.
72. Spuijbroek M.D., Dunselman G.A., Menheere P.P., Evers J.L. Early endometriosis invades the extracellular matrix. Fertil. Steril. 58:1992;929-933.
73. Saito T., Mizumoto H., Kuroki K., Fujii M., Mori S., Kudo R. Expression of MMP-3 and TIMP-1 in endometriosis and the influence of Danazol. Acta Obstet Gynecol. Jpn. 47:1995;495-496.
74. Sharpe-Timms K.L., Keisler L.W., McIntush E.W., Keisler D.H. Tissue inhibitors of metallproteinase-1 concentration are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin releasing hormone-agonist therapy. Fertil. Steril. 69:1998;1128-1134.
75. Chung H.W., Wen Y., Chun S.H., Nezhat C., Woo B.H., Lake Polan M. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rational for endometriotic invasiveness. Fertil. Steril. 75:2001;152-159.
76. Szamatowicz J., Laudanski P., Tomaszewaska I. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Hum. Reprod. 17:2002;284-288.
77. Sillem M., Prifti S., Koch A., Neher M., Jauckus J., Runnebaum B. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 95:2001;167-174.
78. Cox K.E., Piva M., Sharpe-Timms L. Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium. Biol. Reprod. 65:2001;1297-1303.
79. Sharpe-Timms K.L., Cox K.E. Paracrine regulation of matrix metalloproteinase expression in endometriosis. Ann. N. Y. Acad. Sci. 955:2002;147-156.
80. Osteen K.G., Bruner-Tran K.L., Ong D., Eisenberg E. Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis. Ann. N. Y. Acad. Sci. 955:2002;139-146.
81. Cossins J., Dudgeon T.J., Catlin G., Gearing A.J., Clements J.M. Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem. Biophys. Res. Commun. 228:1996;494-498.
82. Garcia R., Ballesteros L.M., Hernandez-Perez O., Rosales A.M., Espinosa R., Soto H.et al. Metalloproteinase activity during growth. Anim. Reprod. Sci. 47:1997;211-228.
83. Bagavandoss P. Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary. J. Endocrinol. 158:1998;221-228.
84. Cooke R.G. 3rd, Nothnick W.B., Komar C., Burns P., Curry T.E. Jr. Collagenase and gelatinase messenger ribonucleic acid expression and activity during follicular development in the rat ovary. Biol. Reprod. 61:1999;1309-1316.
85. Curry T.E. Jr., Song L., Wheeler S.E. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat. Biol. Reprod. 65:2001;855-865.
86. Riley S.C., Gibson A.H., Leask R., Mauchline D.J., Pedersen H.G., Watson E.D. Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries. Reproduction. 121:2001;553-560.
87. Robinson L.L., Sznajder N.A., Riley S.C., Anderson R.A. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary. Mol. Hum. Reprod. 7:2001;641-648.
88. Murdoch W.J. Ovarian surface epithelium during ovulatory and an-ovulatory ovine estrous cycles. Anat. Rec. 240:1994;322-326.
89. Butler T.A., Zhu C., Mueller R.A., Fuller G.C., Lemaire W.J., Woessner J.F. Jr. Inhibition of ovulation in the perfused rat ovary by the synthetic collagenase inhibitor SC 44463. Biol. Reprod. 44:1991;1183-1188.
90. Robker R.L., Russell D.L., Yoshioka S., Sharma S.C., Lydon J.P., O'Malley B.W.et al. Ovulation: a multi-gene, multi-step process. Steroids. 65:2000;559-570.
91. Hagglund A.C., Ny A., Leonardsson G., Ny T. Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation. Endocrinology. 140:1999;4351-4358.
92. Liu K., Wahlberg P., Ny T. Coordinated and cell-specific regulation of embrane type matrix metalloproteinase 1 (MT1-MMP) and its substrate matrix etalloproteinase 2 (MMP-2) by physiological signals during follicular development and ovulation. Endocrinology. 139:1998;4735-5738.
93. 2 receptor in the follicles of porcine ovary and increased expression of matrix metalloproteinase-3 and 20 in cultured granulosa cells by bradykinin treatment. Biol. Reprod. 65:2001;1462-1470.
94. Liu K., Olofsson J.I., Wahlberg P., Ny T. Distinct expression of gelatinase A (matrix metalloproteinase (MMP)-2), collagenase-3 (MMP-13), membrane type MMP-1 (MMP-14) and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum. Endocrinology. 140:1999;5330-5338.
95. Pitzel L., Ludeman S., Wuttke W. Secretion and gene expression of metalloproteinase and gene expression of their inhibitors in porcine corpora lutea at different stages of the luteal phase. Biol. Reprod. 62:2000;1121-1127.
96. Aston K.E., Stamouli A., Thomas E.J., Vyas S., Iredale J.P., Arthur M.J.et al. Effect of gonadotrophin on cell and matrix retention and expression of metalloproteinases and their inhibitor in cultured human granulosa cells modelling corpus luteum function. Mol. Hum. Reprod. 2:1996;26-30.
97. Goldman S., Dirnfeld M., Abramovici H., Kraiem Z. Triiodothyronine and follicle-stimulating hormone, alone and additively together, stimulate production of the tissue inhibitor of metalloproteinases-1 in cultured human luteinized granulosa cells. J. Clin. Endocrinol. Metabol. 82:1997;1869-1873.
98. O'Sullivan M.J., Stamouli A., Thomas E.J., Richardson M.C. Gonadotrophin regulation of production of tissue inhibitor of metalloproteinases-1 by luteinized human granulosa cells: a potential mechanism for luteal rescue. Mol. Hum. Reprod. 5:1997;405-410.
99. Duncan W.C., McNeilly A.S., Illingworth P.J. The effect of luteal "rescue" on the expression and localization of matrix metalloproteinases and their tissue inhibitors in the human corpus luteum. J. Clin. Endocrinol. Metabol. 83:1998;2470-2478.
100. Shalev E., Goldman S., Ben-Shlomo I. The balance between MMP-9 and 2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women. Mol. Hum. Reprod. 7:2001;325-331.
101. Ben-Shlomo I., Goldman S., Shalev E. Regulation of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of MMP (TIMP-1) and progesterone secretion in luteinized granulosa cells from women with normal ovulation and those with polycystic ovarian disease (PCOD). Fertil Steril. 79:2003;649-701.